Contact Us
Drug Search Results
More Filters [+]

Plicamycin

Alternative Names: plicamycin, mithramycin, mithracin
Latest Update: 2022-04-05
Latest Update Note: Clinical Trial Update

Product Description

Mechanisms of Action: RNA polymerase Inhibitor,RNA Synthesis Inhibitor,Protein Synthesis Inhibitor

Novel Mechanism: No

Modality: Large Molecule

Route of Administration: Intravenous

FDA Designation: None *

Approval Status: Approved

Approved Countries: Greece | Ireland | New Zealand | South Africa

Approved Indications: None

Known Adverse Events: None

Company: National Cancer Institute (NCI)
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Plicamycin

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 2: Digestive System Cancer|Mesothelioma|Lung Cancer|Sarcoma, Ewing|Breast Cancer|Esophageal Cancer|Gastrointestinal Cancer|Sarcoma

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success
16-C-0152

P2

Terminated

Sarcoma|Esophageal Cancer|Mesothelioma

2019-12-06

12-C-0151

P2

Terminated

Gastrointestinal Cancer|Digestive System Cancer|Lung Cancer|Esophageal Cancer|Mesothelioma|Breast Cancer

2019-08-20

12-C-0135

P2

Terminated

Sarcoma, Ewing

2014-05-21

Recent News Events

Date

Type

Title

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you’ve used PRYZM, we hope you’re able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions